STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Nautilus Biotechnology, Inc.

Filed

August 26, 2021

Period of Report

August 24, 2021

Accession Number

0001062993-21-007983